Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced today that it has closed the acquisition of Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Atomic Alchemy is pioneering a resilient U.S.-based radioisotope supply chain with its proprietary production and recovery technologies, including its Versatile Isotope Production Reactor (VIPR®) technology. This strategic acquisition enhances Oklo’s capabilities to establish a reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Atomic Alchemy's Radioisotope Production Facility (Image: Hillside Architecture) The acquisition of Atomic Alchemy brings immediate benefits to Oklo’s business: Expanding into an Attractive Market: This acquisition diversifies Oklo’s business and market reach into new sectors such as biotech, pharmaceuticals, space,

Oklo collaborates with the U.S. DOE and Oak Ridge National Laboratory to advance next generation materials development.

Oklo is developing a suite of nuclear solutions under a "full value chain" approach that involves managing smaller reactors' design, build, and operation through power purchase agreements (PPAs).